BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 11307323)

  • 1. [Beta 2-microglobulin and dialysis-related amyloidosis].
    Gejyo F
    Rinsho Byori; 2001 Mar; 49(3):244-8. PubMed ID: 11307323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Historical background and clinical treatment of dialysis-related amyloidosis.
    Yamamoto S; Gejyo F
    Biochim Biophys Acta; 2005 Nov; 1753(1):4-10. PubMed ID: 16226497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dialysis-related amyloidosis and clinical significance of extracorporeal removal of beta2-microglobulin.
    Gejyo F; Suzuki S; Arakawa M
    Ther Apher; 1997 May; 1(2):126-8. PubMed ID: 10225756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new therapeutic approach to dialysis amyloidosis: intensive removal of beta 2-microglobulin with adsorbent column.
    Gejyo F; Homma N; Hasegawa S; Arakawa M
    Artif Organs; 1993 Apr; 17(4):240-3. PubMed ID: 8498903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin amyloidosis in chronic dialysis patients: a case report and review of the literature.
    Farrell J; Bastani B
    J Am Soc Nephrol; 1997 Mar; 8(3):509-14. PubMed ID: 9071720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta2-microglobulin and amyloidosis.
    Drüeke TB
    Nephrol Dial Transplant; 2000; 15 Suppl 1():17-24. PubMed ID: 10737162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2-microglobulin and renal bone disease.
    Wada T; Miyata T; Sakai H; Kurokawa K
    Perit Dial Int; 1999; 19 Suppl 2():S413-6. PubMed ID: 10406556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialysis-related amyloidosis.
    Dzido G; Sprague SM
    Minerva Urol Nefrol; 2003 Jun; 55(2):121-9. PubMed ID: 12847416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nontransplant therapy for dialysis-related amyloidosis.
    Copley JB; Lindberg JS
    Semin Dial; 2001; 14(2):94-8. PubMed ID: 11264774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta2-microglobulin-derived amyloidosis: an update.
    Floege J; Ketteler M
    Kidney Int Suppl; 2001 Feb; 78():S164-71. PubMed ID: 11169004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hemodialysis membranes on beta 2-microglobulin amyloidosis.
    Jaradat MI; Moe SM
    Semin Dial; 2001; 14(2):107-12. PubMed ID: 11264777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current clinical and pathogenetic understanding of beta2-m amyloidosis in long-term haemodialysis patients.
    Gejyo F; Narita I
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S45-9. PubMed ID: 15012691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current clinical aspects of dialysis-related amyloidosis in chronic dialysis patients.
    Saito A; Gejyo F
    Ther Apher Dial; 2006 Aug; 10(4):316-20. PubMed ID: 16911183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.
    Miyata T; Inagi R; Kurokawa K
    Miner Electrolyte Metab; 1999; 25(1-2):114-7. PubMed ID: 10207272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carpal tunnel syndrome and beta 2-microglobulin-related amyloidosis in chronic hemodialysis patients.
    Gejyo F; Homma N; Arakawa M
    Blood Purif; 1988; 6(2):125-31. PubMed ID: 3293616
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnosis and treatment of dialysis-related amyloidosis: focusing on carpal tunnel syndrome].
    Nishi S
    Brain Nerve; 2014 Jul; 66(7):783-93. PubMed ID: 24998823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is beta2-microglobulin-related amyloidosis of hemodialysis patients a multifactorial disease? A new pathogenetic approach.
    Cianciolo G; Colí L; La Manna G; Donati G; D'Addio F; Comai G; Ricci D; Dormi A; Wratten M; Feliciangeli G; Stefoni S
    Int J Artif Organs; 2007 Oct; 30(10):864-78. PubMed ID: 17992647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural localization of advanced glycation end products and beta2-microglobulin in dialysis amyloidosis.
    Brancaccio D; Gallieni M; Niwa T; Braidotti P; Coggi G
    J Nephrol; 2000; 13(2):129-36. PubMed ID: 10858976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amyloidosis in hemodialysis patients].
    Bardin T; Zingraff J; Benoît J; Kuntz D; Drüeke T
    Presse Med; 1987 May; 16(18):907-10. PubMed ID: 2954121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis?
    Schwalbe S; Holzhauer M; Schaeffer J; Galanski M; Koch KM; Floege J
    Kidney Int; 1997 Oct; 52(4):1077-83. PubMed ID: 9328948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.